Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Devices » HME-5910617

  • Global Newborn Screening Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 – 2023

  • Publish: June 2017 | Report Code: HME-5910617

* For discount/customization and buying a particular chapter click here or write to us at [email protected]

The global newborn screening market is estimated to grow with the CAGR of approx. 12% during the forecast period (2016 – 2023). Newborn screening is the act of testing newborn child by a simple blood test to diagnose fatal diseases in newborn baby. The global newborn screening market is primarily driven by the following factors:

  • Increasing prevalence of newborn diseases
  • Government support towards newborn child health
  • Rising awareness for pediatric congenital heart disease
  • Technological advancements in newborn screening





The major factor primarily driven the market demand are increasing prevalence of newborn diseases. According to Department for Health Information & Research (DHIR), birth defects also called as congenital anomalies affects millions of babies globally occurring at nearly 1 in every 33 babies born. According to WHO (World Health Organization), globally, it is estimated that nearly 303,000 newborns die in the first 4 weeks of life owing to congenital anomalies every year. There has been high focus on newborn disease therefore world birth defects day is celebrated every year on 3rd March with the vision to raise awareness on birth defects and message regarding birth defects being spread which affect millions of families and sustained focus is required to encourage research, treatment, prevention and services. Increasing prevalence of such disease along with initiatives to raise awareness is creating good possibilities for the newborn screening market. Moreover, government support towards newborn child health, rising awareness for pediatric congenital heart disease and technological advancements in newborn screening are some major factors further boosting the growth of newborn screening market. Lack of proper healthcare infrastructure for newborn babies in developing countries and socio-economic barriers in the implementation of newborn screening are creating hurdles in the market growth.  According to WHO (World Health Organization), across developing countries such as India, China, Brazil etc. approximately half number of newborns and mothers do not get skilled care during and instantly after birth.  Nearly two-thirds of newborn deaths are prevented if known, active health measures are provided during birth and at the first week of life. Therefore, there is a high need for better healthcare infrastructure for the diagnosis and treatment of disease in the developing countries. On the other hand, untapped opportunity in developing countries such as China and India are developing significant opportunity for the market growth.  

 

 

 

Source: OBRC Analysis

The global newborn screening market is segmented into product type, test type and technology.

The product type of global newborn screening market is further segmented into:

  • Newborn disorder screening instruments
  • Newborn hearing screening instruments
  • Reagents & assay kits
  • PulseOximetry Screening





The test type segment is further segmented into:

  • Hearing screening test
  • Critical congenital heart disease (CCHD) test
  • Dry blood spot test




The Technology segment is further segmented into:

  • Hearing screen technology
  • Electrophoresis
  • Tandem Mass Spectrometry
  • Pulse Oximetry Technology
  • DNA based assays
  • Enzymes & Immunoassay







The report scope is widely categorized on the basis of its product type segment which includes newborn disorder screening instruments, newborn hearing screening instruments, reagents & assay kits and pulseoximetry screening.

Geographically, the global newborn screening market has been segmented on the basis of four major regions, which include:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





North America held major share in terms of revenue for the newborn screening market in 2015. The factors that are responsible for the growth of newborn screening market in North America are high government support for developing better healthcare infrastructure in the region.. However, Asia Pacific is expected to be the fastest growing region in the forecast period due to increasing awareness regarding newborn care in the countries such as India & China along with the increasing occurrence of newborn deaths in the region. Increasing Chinese government focus to prevent from Phenylketonuria (a treatable inherited metabolic disease in newborn) is also expected to drive the growth of newborn screening in APAC.

The global newborn screening market is segmented into product type, test type and technology. Based on product type, the market is further classified into newborn disorder screening instruments, newborn hearing screening instruments, reagents & assay kits and pulseoximetry screening. Based on test type, the market is further classified into hearing screen test, critical congenital heart disease (CCHD) test and dry blood spot test. Critical Congenital Heart Disease (CCHD) is one of the major test type segments as it is generally occurring disorders that is screened by utilizing the pulse-oximeter based technology. Therefore, the growth of CCHD test segment is expected to boost the market in the forecast period.

Based on technology, the market is further classified into hearing screen technology, electrophoresis, tandem mass spectrometry, pulse oximetry technology, DNA based assays and enzymes & immunoassays. Tandem spectroscopy (MS/MS) is expected to grow with the fastest rate in the forecast period due to its high function for diagnosing a series of conditions under one procedure.

The major market players of the global newborn screening market are:

  • BIO-RAD LABORATORIES, INC.
  • MEDTRONIC PLC
  • THERMO FISHER SCIENTIFIC, INC.
  • PERKINELMER, INC.
  • TRIVITRON HEALTHCARE PVT LTD
  • OTHERS







Detailed analysis of these companies provided in this report comprises: Overview, SCOT Analysis, Product Portfolio, Strategic Initiative and Strategic Analysis. 

These companies are using various strategies such as merger & acquisition, collaboration, partnership and product launching. For example: On Jan. 2016, Trivitron Healthcare is set to introduce its patented NeoMass AAAC Kit which is CE Approved. According to Trivitron, the NeoMass AAAC Kit launch will help to make Trivitron a total solution provider for NBS instruments with Modular Systems, Tandem MS/MS, Automated Systems & Kits related to core panel screening and NeoMass AAAC kit for extended panel screening.

Why to buy the report:

This report will provide you:

  • Provide you the business strategies adopted by market player such as product launch that is on Jan 2016, Trivitron Healthcare launched its patented NeoMass AAAC Kit which is CE Approved.
  • Provide in detail the different segments such as by product type, technology and test type which are affecting the global newborn screening market.
  • Provide you the patent analysis of the newborn screening market.
  • Identify and understand the strength, opportunities, challenges and threat of the newborn screening market.
  • Provide revenues of major players of the market such as Perkinelmer, Inc., Bio-Rad Laboratories, Inc. etc.
  • Provide you various regulatory policies which are affecting the global newborn screening market.







How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global newborn screening market offers the longest chain of market segmentation covering major market segmentation based on products and end users. The report tracks the major market trends in the global newborn screening market such as constant innovations in newborn screening, increasing fertility rates and so on.  For each market segments covered in global newborn screening market report, we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the newborn screening industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360-degree analysis, See Saw analysis, and Porter five force models and so on. For the high level analysis in the report we provide a comparative analysis of historic and current year data. 

Key Findings of the global Newborn Screening market.

  • Increasing adoption of newborn screening instruments such as reagents & assay kits and newborn disorder screening instruments is fueling growth in global newborn screening market.
  • North America is anticipated to account the largest revenue share in 2016.
  • Dry blood spot test segment is the dominating segment as the card utilized for testing has been provided free in North America according to the plan in order to encourage higher procedure volume.
  • Increasing government funding and awareness programs for newborn health.
  • Product launch is the key strategy adopted by the various market players of global newborn screening market. 
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL NEWBORN SCREENING MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. INCREASING PREVALENCE OF NEWBORN DISEASES
3.1.2. GOVERNMENT SUPPORT TOWARDS NEWBORN CHILD HEALTH
3.1.3. RISING AWARENESS FOR PEDIATRIC CONGENITAL HEART DISEASE
3.1.4. TECHNOLOGICAL ADVANCEMENTS IN NEWBORN SCREENING
3.2. MARKET RESTRAINTS
3.2.1. LACK OF PROPER HEALTHCARE INFRASTRUCTURE FOR NEWBORN BABIES IN DEVELOPING COUNTRIES
3.2.2. SOCIO-ECONOMIC BARRIERS IN THE IMPLEMENTATION OF NEWBORN CHILD SCREENING
3.3. MARKET OPPORTUNITIES
3.3.1. INCREASING FERTILITY RATES ACROSS THE GLOBE. 
3.3.2. UNTAPPED OPPORTUNITY IN DEVELOPING COUNTRIES
3.4.   MARKET CHALLENGES 
3.4.1. LACK OF SKILLED PROFESSIONALS
 
4. MARKET SEGMENTATION 
4.1. GLOBAL NEWBORN SCREENING MARKET BY PRODUCT TYPE
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION 
4.1.5.1. GLOBAL NEWBORN SCREENING INSTRUMENTS MARKET
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.1.5. MARKET SUB SEGMENTS
4.1.5.1.5.1. HEARING SCREENING INSTRUMENTS
4.1.5.1.5.2. NEWBORN DISORDER SCREENING INSTRUMENTS
4.1.5.1.5.3. PULSE OXIMETRY INSTRUMENTS
4.1.5.2. GLOBAL NEWBORN SCREENING REAGENTS & ASSAY KITS MARKET 
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.2.4. KEY CONCLUSIONS
4.2. GLOBAL NEWBORN SCREENING MARKET BY TEST TYPE
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL HEARING SCREEN TEST MARKET
4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.2.5.1.4. KEY CONCLUSIONS
4.2.5.2. GLOBAL CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST MARKET
4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.2.5.2.4. KEY CONCLUSIONS
4.2.5.3. GLOBAL DRY BLOOD SPOT TEST MARKET
4.2.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.2.5.3.4. KEY CONCLUSIONS
4.3. GLOBAL NEWBORN SCREENING MARKET BY TECHNOLOGY
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION 
4.3.5.1. GLOBAL HEARING SCREEN TECHNOLOGY MARKET
4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.1.4. KEY CONCLUSIONS
4.3.5.2. GLOBAL ELECTROPHORESIS MARKET
4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.2.4. KEY CONCLUSIONS
4.3.5.3. GLOBAL TANDEM MASS SPECTROMETRY MARKET
4.3.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.3.4. KEY CONCLUSIONS
4.3.5.4. GLOBAL PULSE OXIMETRY TECHNOLOGY MARKET
4.3.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.4.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.4.4. KEY CONCLUSIONS
4.3.5.5. GLOBAL DNA BASED ASSAYS MARKET
4.3.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.5.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.5.4. KEY CONCLUSIONS
4.3.5.6. GLOBAL ENZYMES & IMMUNOASSAYS MARKET
4.3.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.6.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.6.4. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS & ACQUISITIONS
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
 
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL NEWBORN SCREENING MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRIAL ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. AB SCIEX LLC (U.S.)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES 
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
7.2. AGILENT TECHNOLOGIES, INC. (U.S.)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES 
7.2.4. SCOT ANALYSIS 
7.2.5. STRATEGIC ANALYSIS
7.3. BIO TEK INSTRUMENTS, INC. (U.S.)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES 
7.3.4. SCOT ANALYSIS
7.3.5. STRATEGIC ANALYSIS
7.4. BIO-RAD LABORATORIES, INC. (U.S.)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES 
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
7.5. CARDINAL HEALTH, INC. (U.S.)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES 
7.5.4. SCOT ANALYSIS 
7.5.5. STRATEGIC ANALYSIS
7.6. GE HEALTHCARE (UK)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES 
7.6.4. SCOT ANALYSIS 
7.6.5. STRATEGIC ANALYSIS
7.7. MASIMO CORPORATION (U.S.)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES 
7.7.4. SCOT ANALYSIS 
7.7.5. STRATEGIC ANALYSIS
7.8. MEDTRONIC PLC (U.S.)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES 
7.8.4. SCOT ANALYSIS 
7.8.5. STRATEGIC ANALYSIS
7.9. NATUS MEDICAL, INC. (U.S.)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES 
7.9.4. SCOT ANALYSIS 
7.9.5. STRATEGIC ANALYSIS
7.10. NEOGEN LABS PVT. LTD. (INDIA)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES 
7.10.4. SCOT ANALYSIS 
7.10.5. STRATEGIC ANALYSIS
7.11. PERKINELMER, INC. (U.S.) 
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES 
7.11.4. SCOT ANALYSIS
7.11.5. STRATEGIC ANALYSIS
7.12. THERMO FISHER SCIENTIFIC, INC. (U.S.)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES 
7.12.4. SCOT ANALYSIS
7.12.5. STRATEGIC ANALYSIS
7.13. TRIVIRON HEALTHCARE PVT. LTD. (INDIA)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES 
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. WATERS CORPORATION (U.S.)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES 
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. ZEN TECH S.A. (BELGIUM)
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES 
7.15.4. SCOT ANALYSIS
7.15.5. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL NEWBORN SCREENING MARKET BY PRODUCT TYPE 2014-2023 ($ MILLION)
2. GLOBAL NEWBORN DISORDER SCREENING INSTRUMENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL NEWBORN SCREENING REAGENTS & ASSAY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL NEWBORN SCREENING MARKET BY TEST TYPE 2014-2023 ($ MILLION)
5. GLOBAL HEARING SCREENING TEST MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
6. GLOBAL CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
7. GLOBAL DRY BLOOD SPOT TEST MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL NEWBORN SCREENING MARKET BY TECHNOLOGY 2014-2023 ($ MILLION)
9. GLOBAL HEARING SCREEN TECHNOLOGY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
10. GLOBAL ELECTROPHORESIS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
11. GLOBAL TANDEM MASS SPECTROMETRY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
12. GLOBAL PULSE OXIMETRY TECHNOLOGY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
13. GLOBAL DNA BASED ASSAYS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
14. GLOBAL ENZYMES & IMMUNOASSAYS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
15. NORTH AMERICA NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
16. EUROPE NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
17. ASIA PACIFIC NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
18. REST OF THE WORLD NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
 
LIST OF FIGURES
 
1. GLOBAL NEWBORN DISORDER SCREENING INSTRUMENTS MARKET 2014-2023 ($ MILLION)
2. GLOBAL NEWBORN SCREENING REAGENTS & ASSAY MARKET 2014-2023 ($ MILLION)
3. GLOBAL DRY BLOOD SPOT TEST MARKET 2014-2023 ($ MILLION)
4. GLOBAL HEARING SCREENING TEST MARKET 2014-2023 ($ MILLION)
5. GLOBAL CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST MARKET 2014-2023 ($ MILLION)
6. GLOBAL HEARING SCREEN TECHNOLOGY MARKET 2014-2023 ($ MILLION)
7. GLOBAL ELECTROPHORESIS MARKET 2014-2023 ($ MILLION)
8. GLOBAL TANDEM MASS SPECTROMETRY MARKET 2014-2023 ($ MILLION)
9. GLOBAL PULSE OXIMETRY TECHNOLOGY MARKET 2014-2023 ($ MILLION)
10. GLOBAL DNA BASED ASSAYS MARKET 2014-2023 ($ MILLION)
11. GLOBAL ENZYMES & IMMUNOASSAYS MARKET 2014-2023 ($ MILLION)
12. UNITED STATES (U.S.) NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
13. CANADA NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
14. UNITED KINGDOM (UK) NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
15. FRANCE NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
16. GERMANY NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
17. SPAIN NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
18. ROE NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
19. INDIA NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
20. CHINA NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
21. JAPAN NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
22. AUSTRALIA NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
23. ROAPAC NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
24. LATIN AMERICA NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
25. MENA NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample
Select License Type
Required More Information

0731 4042636

+91 9713031393

NAVIGATION LINK

OUR SERVICES

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: [email protected]

 

 

  • facebook
  • twitter
  • blog
  • linkdin
  • google plus
  • youtube
Go To Top
viewthroughconversion